Symbols / SNN Stock $30.40 -0.43% Smith & Nephew plc

Healthcare • Medical Devices • United Kingdom • NYQ
SNN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Deepak S. Nath Ph.D.
Exch · Country NYQ · United Kingdom
Market Cap 12.93B
Enterprise Value 28.71B
Income 625.00M
Sales 6.16B
FCF (ttm) 876.63M
Book/sh 2.49
Cash/sh 0.66
Employees 16,988
Insider 10d —
IPO Nov 16, 1999
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 53.21%
P/E 21.26
Forward P/E 13.95
PEG 1.23
P/S 2.10
P/B 12.21
P/C —
EV/EBITDA 21.49
EV/Sales 4.66
Quick Ratio 1.17
Current Ratio 2.57
Debt/Eq 62.90
LT Debt/Eq —
EPS (ttm) 1.43
EPS next Y 2.18
EPS Growth 70.40%
Revenue Growth 7.40%
EPS Gr Q/Q 67.70%
Rev Gr Q/Q —
Earnings (next) 2026-03-02
Earnings (prior) 2026-03-02
ROA 5.27%
ROE 11.84%
ROIC —
Gross Margin 68.25%
Oper. Margin 13.99%
Profit Margin 10.14%
Shs Outstand 425.44M
Shs Float 839.99M
Insider Own 0.01%
Instit Own 7.69%
Short Float 0.69%
Short Ratio 2.90
Short Interest 2.95M
52W High 38.79
vs 52W High -21.63%
52W Low 28.40
vs 52W Low 7.04%
Beta 0.67
Impl. Vol. 60.45%
Rel Volume 1.08
Avg Volume 1.07M
Volume 1.16M
Target (mean) $34.99
Tgt Median $35.11
Tgt Low $30.00
Tgt High $40.00
# Analysts 5
Recom Buy
Prev Close $30.53
Price $30.40
Change -0.43%
About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$34.99
Mean price target
2. Current target
$30.47
Latest analyst target
3. DCF / Fair value
$37.09
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$30.47
Low
$30.00
High
$40.00
Mean
$34.99

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-11 main Canaccord Genuity Hold → Hold $30
2026-03-05 main Canaccord Genuity Hold → Hold $35
2025-11-11 main Canaccord Genuity Hold → Hold $34
2025-10-14 down Bernstein Outperform → Market Perform $38
2025-08-18 main Canaccord Genuity Hold → Hold $36
2025-05-01 main Canaccord Genuity Hold → Hold $28
2025-03-17 main Canaccord Genuity Hold → Hold $27
2025-03-12 down UBS Buy → Neutral —
2025-02-26 main Canaccord Genuity Hold → Hold $27
2024-06-05 up UBS Neutral → Buy —
2023-10-04 main Bernstein Outperform → Outperform $33
2022-03-04 up Redburn Partners Sell → Neutral —
2021-04-30 main Canaccord Genuity — → Buy $55
2020-12-18 up Bernstein Market Perform → Outperform $47
2020-10-30 main Canaccord Genuity — → Buy $48
2020-05-07 main CFRA — → Hold $42
2020-02-21 main CFRA — → Hold $52
2019-11-12 init Bernstein — → Outperform —
2019-04-25 main Canaccord Genuity Buy → Buy $45
2018-08-08 down UBS Buy → Neutral —
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-14 BlackRock Investment Management (UK) Ltd. — — 946 — —
2025-11-11 Connolly (Paul) — — 25 $33.29 $832
2025-11-11 Gaffin (Craig) — — 23 $33.29 $765
2025-11-11 Kebede (Mizanu) — — 12 $33.29 $399
2025-11-11 Nath (Deepak S) — — 25 $33.29 $832
2025-11-11 Schaffner (Scott) — — 29 $33.29 $965
2025-11-10 BlackRock Investment Management (UK) Ltd. — — 437,015 — —
2025-11-06 Dhankhar (Ajay) — — 18,460 $32.58 $601,426
2025-11-06 Kong (Garheng) — — 3,000 $33.98 $101,940
2025-10-22 BlackRock Investment Management (UK) Ltd. — — 435,514 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
6,164.00
+6.09%
5,810.00
+4.70%
5,549.00
+6.40%
5,215.00
Operating Revenue
6,164.00
+6.09%
5,810.00
+4.70%
5,549.00
+6.40%
5,215.00
Cost Of Revenue
1,972.00
+11.79%
1,764.00
+1.97%
1,730.00
+12.34%
1,540.00
Reconciled Cost Of Revenue
1,972.00
+11.79%
1,764.00
+1.97%
1,730.00
+12.34%
1,540.00
Gross Profit
4,192.00
+3.61%
4,046.00
+5.94%
3,819.00
+3.92%
3,675.00
Operating Expense
3,335.00
+4.68%
3,186.00
-0.41%
3,199.00
+5.20%
3,041.00
Research And Development
296.00
+2.42%
289.00
-14.75%
339.00
-1.74%
345.00
Selling General And Administration
2,790.00
+5.20%
2,652.00
+1.92%
2,602.00
+6.86%
2,435.00
Selling And Marketing Expense
2,362.00
+3.78%
2,276.00
+2.61%
2,218.00
+7.36%
2,066.00
General And Administrative Expense
428.00
+13.83%
376.00
-2.08%
384.00
+4.07%
369.00
Total Expenses
5,307.00
+7.21%
4,950.00
+0.43%
4,929.00
+7.60%
4,581.00
Operating Income
857.00
-0.35%
860.00
+38.71%
620.00
-2.21%
634.00
Total Operating Income As Reported
794.00
+20.85%
657.00
+54.59%
425.00
-5.56%
450.00
EBITDA
1,532.00
+25.47%
1,221.00
+27.72%
956.00
+9.38%
874.00
Normalized EBITDA
1,595.00
+12.01%
1,424.00
+23.72%
1,151.00
+8.79%
1,058.00
Reconciled Depreciation
574.00
+3.42%
555.00
+5.31%
527.00
-3.83%
548.00
EBIT
958.00
+43.84%
666.00
+55.24%
429.00
+31.60%
326.00
Total Unusual Items
-63.00
+68.97%
-203.00
-4.10%
-195.00
-5.98%
-184.00
Total Unusual Items Excluding Goodwill
-63.00
+68.97%
-203.00
-4.10%
-195.00
-5.98%
-184.00
Special Income Charges
-63.00
+68.97%
-203.00
-4.10%
-195.00
-5.98%
-184.00
Other Special Charges
1.00
-94.74%
19.00
+90.00%
10.00
-72.22%
36.00
Restructuring And Mergern Acquisition
62.00
-66.30%
184.00
-0.54%
185.00
+25.00%
148.00
Net Income
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Pretax Income
779.00
+56.43%
498.00
+71.72%
290.00
+23.40%
235.00
Net Non Operating Interest Income Expense
-128.00
+14.09%
-149.00
-41.90%
-105.00
-41.89%
-74.00
Interest Expense Non Operating
179.00
+6.55%
168.00
+20.86%
139.00
+52.75%
91.00
Net Interest Income
-128.00
+14.09%
-149.00
-41.90%
-105.00
-41.89%
-74.00
Interest Expense
179.00
+6.55%
168.00
+20.86%
139.00
+52.75%
91.00
Interest Income Non Operating
28.00
+16.67%
24.00
-29.41%
34.00
+142.86%
14.00
Interest Income
28.00
+16.67%
24.00
-29.41%
34.00
+142.86%
14.00
Tax Provision
154.00
+79.07%
86.00
+218.52%
27.00
+125.00%
12.00
Tax Rate For Calcs
0.00
+14.48%
0.00
+85.48%
0.00
+82.33%
0.00
Tax Effect Of Unusual Items
-12.45
+64.47%
-35.06
-93.09%
-18.16
-93.23%
-9.40
Net Income Including Noncontrolling Interests
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Net Income From Continuing Operation Net Minority Interest
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Net Income From Continuing And Discontinued Operation
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Net Income Continuous Operations
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Normalized Income
675.55
+16.48%
579.94
+31.85%
439.84
+10.62%
397.60
Net Income Common Stockholders
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
0.00
Diluted EPS
1.43
+52.34%
0.94
+56.15%
0.60
+20.40%
0.50
Basic EPS
1.44
+52.75%
0.94
+56.29%
0.60
+20.80%
0.50
Basic Average Shares
433.43
-0.69%
436.44
+0.23%
435.43
-2.37%
446.00
Diluted Average Shares
436.45
-0.42%
438.30
+0.33%
436.88
-2.05%
446.00
Diluted NI Availto Com Stockholders
625.00
+51.70%
412.00
+56.65%
263.00
+17.94%
223.00
Amortization
249.00
+1.63%
245.00
-5.04%
258.00
-1.15%
261.00
Depreciation And Amortization In Income Statement
249.00
+1.63%
245.00
-5.04%
258.00
-1.15%
261.00
Depreciation Income Statement
0.00
0.00
0.00
0.00
Total Other Finance Cost
-23.00
-560.00%
5.00
—
-3.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
10,457.00
+0.99%
10,354.00
+3.67%
9,987.00
+0.21%
9,966.00
Current Assets
4,103.00
-7.19%
4,421.00
+9.70%
4,030.00
+4.51%
3,856.00
Cash Cash Equivalents And Short Term Investments
557.00
-10.02%
619.00
+104.97%
302.00
-13.71%
350.00
Cash And Cash Equivalents
557.00
-10.02%
619.00
+104.97%
302.00
-13.71%
350.00
Cash Equivalents
100.00
-50.00%
200.00
—
—
Cash Financial
457.00
+9.07%
419.00
+38.74%
302.00
-13.71%
350.00
Accounts Receivable
1,156.00
+9.16%
1,059.00
+0.00%
1,059.00
+3.12%
1,027.00
Gross Accounts Receivable
1,200.00
+9.09%
1,100.00
-0.36%
1,104.00
+2.60%
1,076.00
Allowance For Doubtful Accounts Receivable
-44.00
-7.32%
-41.00
+8.89%
-45.00
+8.16%
-49.00
Other Receivables
138.00
-6.76%
148.00
+21.31%
122.00
+7.02%
114.00
Taxes Receivable
16.00
-52.94%
34.00
+3.03%
33.00
-10.81%
37.00
Inventory
2,117.00
-11.31%
2,387.00
-0.33%
2,395.00
+8.62%
2,205.00
Raw Materials
412.00
-12.15%
469.00
-6.76%
503.00
+6.12%
474.00
Work In Process
54.00
+20.00%
45.00
-25.00%
60.00
-23.08%
78.00
Finished Goods
1,651.00
-11.85%
1,873.00
+2.24%
1,832.00
+10.83%
1,653.00
Prepaid Assets
99.00
-22.05%
127.00
+38.04%
92.00
+21.05%
76.00
Hedging Assets Current
20.00
-57.45%
47.00
+74.07%
27.00
-42.55%
47.00
Total Non Current Assets
6,354.00
+7.10%
5,933.00
-0.40%
5,957.00
-2.50%
6,110.00
Net PPE
1,638.00
+15.19%
1,422.00
-3.27%
1,470.00
+1.03%
1,455.00
Gross PPE
4,728.00
+10.36%
4,284.00
+0.99%
4,242.00
+5.42%
4,024.00
Accumulated Depreciation
-3,090.00
-7.97%
-2,862.00
-3.25%
-2,772.00
-7.90%
-2,569.00
Properties
778.00
-1.39%
789.00
-0.75%
795.00
+9.50%
726.00
Machinery Furniture Equipment
3,743.00
+10.97%
3,373.00
+2.93%
3,277.00
+7.73%
3,042.00
Construction In Progress
207.00
+69.67%
122.00
-28.24%
170.00
-33.59%
256.00
Goodwill And Other Intangible Assets
3,990.00
-1.68%
4,058.00
-1.07%
4,102.00
-3.87%
4,267.00
Goodwill
3,108.00
+2.71%
3,026.00
+1.14%
2,992.00
-1.29%
3,031.00
Other Intangible Assets
882.00
-14.53%
1,032.00
-7.03%
1,110.00
-10.19%
1,236.00
Long Term Equity Investment
121.00
+1628.57%
7.00
-56.25%
16.00
-65.22%
46.00
Other Investments
—
—
—
12.00
Non Current Deferred Taxes Assets
347.00
-0.86%
350.00
+27.74%
274.00
+54.80%
177.00
Other Non Current Assets
164.00
+583.33%
24.00
+33.33%
18.00
+50.00%
12.00
Total Liabilities Net Minority Interest
5,168.00
+1.55%
5,089.00
+6.69%
4,770.00
+1.34%
4,707.00
Current Liabilities
1,595.00
+4.18%
1,531.00
-32.58%
2,271.00
+32.42%
1,715.00
Payables
1,360.00
+1.34%
1,342.00
+7.79%
1,245.00
-1.89%
1,269.00
Accounts Payable
1,160.00
+7.21%
1,082.00
+6.50%
1,016.00
-1.26%
1,029.00
Other Payable
6.00
-78.57%
28.00
+154.55%
11.00
-57.69%
26.00
Total Tax Payable
194.00
-16.38%
232.00
+6.42%
218.00
+1.87%
214.00
Current Debt And Capital Lease Obligation
150.00
+138.10%
63.00
-91.76%
765.00
+378.13%
160.00
Current Debt
83.00
+4050.00%
2.00
-99.72%
710.00
+539.64%
111.00
Current Capital Lease Obligation
67.00
+9.84%
61.00
+10.91%
55.00
+12.24%
49.00
Total Non Current Liabilities Net Minority Interest
3,573.00
+0.42%
3,558.00
+42.38%
2,499.00
-16.48%
2,992.00
Long Term Debt And Capital Lease Obligation
3,177.00
-2.49%
3,258.00
+40.49%
2,319.00
-14.49%
2,712.00
Long Term Debt
3,028.00
-3.04%
3,123.00
+43.59%
2,175.00
-15.20%
2,565.00
Long Term Capital Lease Obligation
149.00
+10.37%
135.00
-6.25%
144.00
-2.04%
147.00
Long Term Provisions
82.00
-13.68%
95.00
+97.92%
48.00
-42.86%
84.00
Defined Pension Benefit
64.00
+1.59%
63.00
-8.70%
69.00
-51.06%
141.00
Non Current Pension And Other Postretirement Benefit Plans
84.00
+6.33%
79.00
-10.23%
88.00
+25.71%
70.00
Tradeand Other Payables Non Current
184.00
+132.91%
79.00
+125.71%
35.00
-54.55%
77.00
Non Current Deferred Taxes Liabilities
40.00
+29.03%
31.00
+244.44%
9.00
-75.00%
36.00
Stockholders Equity
5,289.00
+0.46%
5,265.00
+0.92%
5,217.00
-0.80%
5,259.00
Common Stock Equity
5,289.00
+0.46%
5,265.00
+0.92%
5,217.00
-0.80%
5,259.00
Capital Stock
175.00
+0.00%
175.00
+0.00%
175.00
+0.00%
175.00
Common Stock
175.00
+0.00%
175.00
+0.00%
175.00
+0.00%
175.00
Share Issued
877.72
+0.00%
877.70
+0.00%
877.67
+0.00%
877.65
Ordinary Shares Number
849.36
-2.76%
873.49
+0.19%
871.83
+0.19%
870.14
Treasury Shares Number
28.36
+572.68%
4.22
-27.81%
5.84
-22.19%
7.51
Additional Paid In Capital
635.00
+0.00%
635.00
+0.00%
635.00
+0.00%
635.00
Retained Earnings
5,323.00
+6.08%
5,018.00
+2.28%
4,906.00
-2.39%
5,026.00
Treasury Stock
515.00
+680.30%
66.00
-29.79%
94.00
-20.34%
118.00
Total Equity Gross Minority Interest
5,289.00
+0.46%
5,265.00
+0.92%
5,217.00
-0.80%
5,259.00
Total Capitalization
8,317.00
-0.85%
8,388.00
+13.47%
7,392.00
-5.52%
7,824.00
Working Capital
2,508.00
-13.22%
2,890.00
+64.30%
1,759.00
-17.84%
2,141.00
Invested Capital
8,400.00
+0.12%
8,390.00
+3.55%
8,102.00
+2.10%
7,935.00
Total Debt
3,327.00
+0.18%
3,321.00
+7.68%
3,084.00
+7.38%
2,872.00
Net Debt
2,554.00
+1.92%
2,506.00
-2.98%
2,583.00
+11.05%
2,326.00
Capital Lease Obligations
216.00
+10.20%
196.00
-1.51%
199.00
+1.53%
196.00
Net Tangible Assets
1,299.00
+7.62%
1,207.00
+8.25%
1,115.00
+12.40%
992.00
Tangible Book Value
1,299.00
+7.62%
1,207.00
+8.25%
1,115.00
+12.40%
992.00
Current Provisions
74.00
-31.48%
108.00
-53.65%
233.00
-4.12%
243.00
Derivative Product Liabilities
6.00
-62.50%
16.00
0.00
-100.00%
13.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
30.00
+233.33%
9.00
+12.50%
8.00
-33.33%
12.00
Investmentin Financial Assets
30.00
+233.33%
9.00
+12.50%
8.00
-33.33%
12.00
Investmentsin Associatesat Cost
121.00
+1628.57%
7.00
-56.25%
16.00
-65.22%
46.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,285.00
+30.19%
987.00
+62.34%
608.00
+29.91%
468.00
Net Income From Continuing Operations
779.00
+56.43%
498.00
+71.72%
290.00
+23.40%
235.00
Depreciation
335.00
+3.08%
325.00
+6.21%
306.00
-4.08%
319.00
Amortization Cash Flow
239.00
+3.91%
230.00
+4.07%
221.00
-3.49%
229.00
Depreciation And Amortization
574.00
+3.42%
555.00
+5.31%
527.00
-3.83%
548.00
Other Non Cash Items
112.00
-7.44%
121.00
+23.47%
98.00
+48.48%
66.00
Pension And Employee Benefit Expense
5.00
-68.75%
16.00
+433.33%
3.00
-50.00%
6.00
Stock Based Compensation
43.00
+7.50%
40.00
+2.56%
39.00
-2.50%
40.00
Gain Loss On Investment Securities
1.00
—
4.00
—
Gain Loss On Sale Of PPE
23.00
+4.55%
22.00
+22.22%
18.00
+63.64%
11.00
Change In Working Capital
127.00
+218.69%
-107.00
+67.77%
-332.00
+37.94%
-535.00
Change In Receivables
-175.00
-116.05%
-81.00
-65.31%
-49.00
+52.43%
-103.00
Change In Inventory
208.00
+595.24%
-42.00
+76.40%
-178.00
+56.27%
-407.00
Change In Payable
94.00
+487.50%
16.00
+115.24%
-105.00
-320.00%
-25.00
Investing Cash Flow
-406.00
+28.65%
-569.00
-27.01%
-448.00
+5.08%
-472.00
Net PPE Purchase And Sale
38.00
0.00
0.00
—
Sale Of PPE
38.00
0.00
0.00
—
Capital Expenditure
-433.00
-13.65%
-381.00
+10.77%
-427.00
-19.27%
-358.00
Capital Expenditure Reported
-433.00
-13.65%
-381.00
+10.77%
-427.00
-19.27%
-358.00
Net Investment Purchase And Sale
-2.00
-100.00%
-1.00
0.00
+100.00%
-2.00
Purchase Of Investment
-2.00
-100.00%
-1.00
0.00
+100.00%
-2.00
Net Business Purchase And Sale
-9.00
+95.19%
-187.00
-790.48%
-21.00
+81.25%
-112.00
Purchase Of Business
-9.00
+95.19%
-187.00
-790.48%
-21.00
+81.42%
-113.00
Gain Loss On Sale Of Business
—
—
0.00
0.00
Financing Cash Flow
-955.00
-1010.47%
-86.00
+57.00%
-200.00
+78.40%
-926.00
Net Issuance Payments Of Debt
-86.00
-129.15%
295.00
+68.57%
175.00
+144.19%
-396.00
Issuance Of Debt
43.00
-95.70%
1,000.00
+206.75%
326.00
-32.78%
485.00
Repayment Of Debt
-129.00
+81.70%
-705.00
-366.89%
-151.00
+82.86%
-881.00
Long Term Debt Issuance
0.00
-100.00%
1,000.00
0.00
-100.00%
485.00
Long Term Debt Payments
-90.00
0.00
0.00
+100.00%
-474.00
Net Long Term Debt Issuance
-90.00
-109.00%
1,000.00
0.00
-100.00%
11.00
Short Term Debt Issuance
43.00
0.00
-100.00%
326.00
0.00
Short Term Debt Payments
-39.00
+94.47%
-705.00
-366.89%
-151.00
+62.90%
-407.00
Net Short Term Debt Issuance
4.00
+100.57%
-705.00
-502.86%
175.00
+143.00%
-407.00
Net Common Stock Issuance
-490.00
-49100.00%
1.00
0.00
+100.00%
-152.00
Common Stock Payments
-502.00
0.00
0.00
+100.00%
-158.00
Common Stock Dividend Paid
-330.00
-0.92%
-327.00
+0.00%
-327.00
+0.00%
-327.00
Cash Dividends Paid
-330.00
-0.92%
-327.00
+0.00%
-327.00
+0.00%
-327.00
Repurchase Of Capital Stock
-502.00
0.00
0.00
+100.00%
-158.00
Net Other Financing Charges
1.00
—
4.00
+33.33%
3.00
Changes In Cash
-76.00
-122.89%
332.00
+930.00%
-40.00
+95.70%
-930.00
Effect Of Exchange Rate Changes
12.00
+180.00%
-15.00
-275.00%
-4.00
+63.64%
-11.00
Beginning Cash Position
617.00
+105.67%
300.00
-12.79%
344.00
-73.23%
1,285.00
End Cash Position
553.00
-10.37%
617.00
+105.67%
300.00
-12.79%
344.00
Free Cash Flow
852.00
+40.59%
606.00
+234.81%
181.00
+64.55%
110.00
Common Stock Issuance
12.00
+1100.00%
1.00
0.00
-100.00%
6.00
Dividends Received CFI
—
—
0.00
-100.00%
1.00
Interest Paid CFO
-142.00
-1.43%
-140.00
-34.62%
-104.00
-42.47%
-73.00
Interest Received CFO
25.00
+13.64%
22.00
+175.00%
8.00
+14.29%
7.00
Issuance Of Capital Stock
12.00
+1100.00%
1.00
0.00
-100.00%
6.00
Sale Of Business
—
—
—
1.00
Taxes Refund Paid
-147.00
-5.00%
-140.00
-12.00%
-125.00
-165.96%
-47.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category